Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_assertion type Assertion NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_head.
- NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_provenance.
- NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_assertion evidence source_evidence_literature NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_provenance.
- NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_assertion SIO_000772 15920493 NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_provenance.
- NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_assertion wasDerivedFrom befree-2016 NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_provenance.
- NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_assertion wasGeneratedBy ECO_0000203 NP496705.RAPIVIVAvULJb_us00BuAHulsfO_Pg6I4VFLzPbPaTcxU130_provenance.